Inventa Therapeutics is a U.K based Bio-Pharmaceutical Organization. We have a unique business model to develop and commercialize new therapies for patients with unmet medical needs by licensing and collaborating with discovery companies world-wide. This collaboration would allow Inventa to In-License highly differentiated, best-in-class therapeutics with strong global intellectual property portfolio covering New Molecular Entities to treat significant and life-threatening diseases. The NMEs are composed of compounds and compositions utilizing a novel product design approach with a rationalized focus to address the significant clinical and patient centric unmet needs of the approved drug molecule with an extensive clinical experience, thus enabling Inventa to strategize the abbreviated clinical development, global regulatory approval and commercialization.
